article thumbnail

In Brain Chemistry We Trust—The Gospel According to Pharma

Mad in America

Depression was sold to us as a simple problem of serotonin insufficiency, a convenient narrative that made drug companies like Eli Lilly, Forest Pharmaceuticals, and Pfizer very rich. As a former pharmaceutical advertising writer, I not only witnessed the explosive growth in antidepressant drugs, I contributed to it.

article thumbnail

Decarbonizing API manufacturing: Unpacking the cost and regulatory requirements

McKensey

A range of existing and emerging decarbonization solutions could help active pharmaceutical ingredient companies reduce their carbon footprint by up to 90 percent.

article thumbnail

Armata Pharmaceuticals Offices – Marina Del Rey

Office Snapshots

for life science research and manufacturing because it is culturally diverse and is home to a multitude of diverse ways of thinking. Design : Worksmart Design Design Team : Mandy Adams, Fiona Chan Photography : RJ Guillermo The post Armata Pharmaceuticals Offices – Marina Del Rey appeared first on Office Snapshots.

article thumbnail

The Editorial Demise of Psychotherapy and Psychosomatics Is Bad News For Us All

Mad in America

The journal continued to be in good hands, and thus one of the few journals that was receptive to research findings that belied the narrative of therapeutic progress that the psychiatric guild and pharmaceutical companies have been promoting for decades. He noted too the reluctance of the field to consider this possibility.

article thumbnail

Where’s Your Visitor?

The Receptionist

In your manufacturing facility, you likely have areas—such as receiving, production, and shipping—that are off-limits for certain personnel and visitors. What’s more, many manufacturing facilities contain industrial equipment that could be dangerous to those who don’t know how to operate it.

article thumbnail

Antidepressant Use Linked to Sexual Dysfunction, Why Aren’t Prescribers Discussing It?

Mad in America

Stephenson and a team of researchers from various academic and pharmaceutical institutions, including the University of Virginia School of Medicine. Maelys Touya was an employee of Lundbeck LLC, and Lambros Chrones was an employee of Takeda Pharmaceuticals U.S.A., The study was authored by Judith J. Additionally, Anita H.

article thumbnail

‘We Hold You Sacred’: Fighting the Opioid Crisis in the Cherokee Nation

Mad in America

From The Guardian : “In 2017, the Cherokee Nation became the first tribe to file a lawsuit against opioid manufacturers and distributors for promoting the flow of prescription opioids into its community.